corporary

BEMIPHARM

Active
SIREN 949752307 VAT number FR79949752307

Business purpose.

étude et réalisations compris construction en tant que contractant général, promoteur dans la construction de bâtiments dans le secteur pharmaco industriel, de la santé et de la cosmétique

Identity

Legal form
SAS, simplified joint-stock company
Activity
Sundry professional, scientific and technical activities (74.90B)
Sector
Other professional, scientific and technical activities
Headcount
3 to 5 employees
Created
8 Mar 2023
Share capital
100,000.00 EUR
Establishments
2

Directors

Other companies at the same address

39 other company head offices are registered at this address.

Establishments

Financial strength

Financial score

49 / 100 D

Confidence: medium · computed on the financial year ended 31 Dec 2024

Equity to assets (4.8 %)
5.2 out of 30
EBITDA margin (6.9 %)
12.9 out of 25
Liquidity (240.4 %)
10.5 out of 20
Debt (41.0 %)
10.1 out of 15
Revenue trend (2,520.8 %)
10.0 out of 10

formula fin-1.0

Legal score

87 / 100 A

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
20.0 out of 20
Age (3.7 years)
7.4 out of 20
Accounts filed recently
20.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Revenue and net income by financial year
2023 2024

Revenue Net income

Financial year Revenue Change EBITDA Net income
31 Dec 2024 2,540,873 € +2,520.8 % 175,159 € 131,936 €
31 Dec 2023 96,950 € first year on record -5,129 € -8,444 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Collective agreements

Agreements declared by the employer in its payroll filings.

  • Convention collective nationale des bureaux d'études techniques, des cabinets d'ingénieurs-conseils et des sociétés de conseils du 15 décembre 1987.

    IDCC 1486 · in force, extended · 1 establishment · declared in August 2026

Legal notices

  • Filing of accounts 17 Sep 2026
    Court :
    Greffe du Tribunal de Commerce d'evry
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2025

    BODACC C n 20260178, annonce n 12528 · Proof of publication (PDF)

  • Amendment 8 Sep 2026
    Court :
    Greffe du Tribunal de Commerce d'Evry
    Amendment :
    Modification survenue sur l'administration.

    BODACC B n 20260171, annonce n 9698 · Proof of publication (PDF)

  • Filing of accounts 13 Jul 2025
    Court :
    Greffe du Tribunal de Commerce d'evry
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2024

    BODACC C n 20250133, annonce n 8024 · Proof of publication (PDF)

  • Filing of accounts 8 Jan 2025
    Court :
    Greffe du Tribunal de Commerce d'evry
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2023

    BODACC C n 20250005, annonce n 3265 · Proof of publication (PDF)

  • Incorporation 14 Mar 2023
    Court :
    Greffe du Tribunal de Commerce d'Evry

    BODACC A n 20230051, annonce n 2335 · Proof of publication (PDF)

Filings and annual accounts as PDF →

Filings and accounts

  • Formality 22 Dec 2025
  • Formality 2 Jun 2023

Change history

  • Change in the register 4 Nov 2026
  • Change in the register 3 Nov 2026
  • Appointed: Commissaire aux comptes titulaire 10 Oct 2026
  • Appointed: President de SAS 10 Oct 2026
  • Appointed: Commissaire aux comptes titulaire 10 Oct 2026
  • Appointed: President de SAS 10 Oct 2026
  • Appointed: Commissaire aux comptes titulaire 10 Oct 2026
  • Appointed: President de SAS 10 Oct 2026
  • Appointed: Commissaire aux comptes titulaire 10 Oct 2026
  • Appointed: President de SAS 10 Oct 2026
  • Appointed: Commissaire aux comptes titulaire 10 Oct 2026
  • Appointed: President de SAS 10 Oct 2026
  • Appointed: Commissaire aux comptes titulaire 10 Oct 2026
  • Appointed: President de SAS 10 Oct 2026
  • Appointed: Commissaire aux comptes titulaire 10 Oct 2026
  • Appointed: President de SAS 10 Oct 2026
  • Appointed: Commissaire aux comptes titulaire 10 Oct 2026
  • Appointed: President de SAS 10 Oct 2026
  • Appointed: Commissaire aux comptes titulaire 10 Oct 2026
  • Appointed: President de SAS 10 Oct 2026
  • Appointed: Commissaire aux comptes titulaire 9 Oct 2026
  • Appointed: President de SAS 9 Oct 2026
  • Appointed: Commissaire aux comptes titulaire 9 Oct 2026
  • Appointed: President de SAS 9 Oct 2026
  • Share capital: 100,000 € 2 Oct 2026
  • Registered office: 3 Avenue de la Baltique 91140 Villebon-sur-Yvette 1 Oct 2026

Frequently asked questions about BEMIPHARM

What is the SIREN number of BEMIPHARM?
The SIREN number of BEMIPHARM is 949752307. Its intra-community VAT number is FR79949752307.
Where is the head office of BEMIPHARM?
Head office address: 3 AVENUE DE LA BALTIQUE, 91140 VILLEBON-SUR-YVETTE.
When was BEMIPHARM founded?
BEMIPHARM was founded on 8 Mar 2023.
What does BEMIPHARM do?
Its declared main activity is: Sundry professional, scientific and technical activities (NAF code 74.90B).
Who runs BEMIPHARM?
The officers listed in the register are EXELMANS ADVISORY (Commissaire aux comptes titulaire), GROUPE BEMING (President de SAS).
What is the revenue of BEMIPHARM?
The latest published revenue is 2,540,873 €, for the 2024 financial year.
How many employees does BEMIPHARM have?
The declared headcount is 3 to 5 employees. Insee data for 2024.
Is BEMIPHARM subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Show this profile on your website →

Report an error or request removal of this data